Yes Or No? Decisions Due On New EU Drug Applications
Executive Summary
Myovant, Bayer and Rhythm Pharmaceuticals are among the companies that could soon learn whether the European Medicines Agency thinks their drugs are fit for approval.
You may also be interested in...
Obesity Drug Imcivree Among Eight New Products To Win EMA Nod
The European Medicines Agency today revealed the names of the latest new products it believes should be approved for use across the EU.
Companies Brace For ‘Oral Explanations’ On EU Filings
Several companies may appear this week before the European Medicines Agency’s human medicines committee, the CHMP, to answer questions about their initial marketing authorization applications or indication extension requests.
EU Crunch Time For Bluebird’s Neurodegenerative Disorder Gene Therapy
The EU could become the first market in which eli-cel is approved if the gene therapy for cerebral adrenoleukodystrophy this week passes muster with the European Medicines Agency.